

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 77.43 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 92.05 | Oscillator | Sell |
| Williams %R (14) | -0.54 | Oscillator | Sell |
| MACD (12, 26, 9) | 3.64 (Hist 3.84) | Oscillator | Strong Buy |
| Average Directional Index (14) | 30.99 (+DI 36.8 / -DI 15.0) | Trend | Strong Buy |
Current price $270.90
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 23, 26 |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Swoboda Charles M | director | A-Award | 124 | — |
| EMA 20 | 243.36 | MA | Strong Buy |
| SMA 20 | 239.12 | MA | Strong Buy |
| EMA 50 | 244.21 | MA | Strong Buy |
| SMA 50 | 242.74 | MA | Strong Buy |
| SMA 200 | 235.42 | MA | Strong Buy |
| Wells Fargo |
| maintain |
| Overweight |
| Overweight |
| Oct 23, 26 | Stephens & Co. | maintain | Overweight | Overweight |
| Oct 23, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 23, 26 | JP Morgan | maintain | Overweight | Overweight |
| Oct 23, 26 | Citigroup | maintain | Buy | Buy |
| Oct 8, 26 | Citigroup | upgrade | Neutral | Buy |
| Oct 5, 26 | JP Morgan | upgrade | Neutral | Overweight |
| Oct 2, 26 | Susquehanna | maintain | Positive | Positive |
| Sep 29, 26 | Baird | downgrade | Outperform | Neutral |
| Aug 28, 26 |
| Fatovic Robert D |
| officer: EVP, CLO & Corp. Secretary |
| G-Gift |
| 403 |
| — |
| Aug 17, 26 | Fatovic Robert D | officer: EVP, CLO & Corp. Secretary | I-Discretionary | 6,344 @ $264.70 | $1.68M |
| Jul 1, 26 | Swoboda Charles M | director | A-Award | 108 | — |
| May 29, 26 | Fatovic Robert D | officer: EVP, CLO & Corp. Secretary | S-Sale | 5,000 @ $249.85 | $1.25M |
| May 27, 26 | Hodes Sanford J. | officer: SVP, C Procur Of, Corp Dev Of | G-Gift | 411 | — |
| May 28, 26 | Hodes Sanford J. | officer: SVP, C Procur Of, Corp Dev Of | S-Sale | 595 @ $251.95 | $149.9K |
| May 1, 26 | Swoboda Charles M | director | A-Award | 191 | — |
Stock news · updated daily
Asset-light operations will generate 60% of expected 2026 revenue. Ryder raised its 2026 comparable earnings forecast to $14.85 to $15.05.
Phase I/II NECVAX-NEO1 trial in patients with triple-negative breast cancer confirm its potential safety and immunogenicity and provide clinical proof-of-concep
TOKYO, Oct 23, 2026 - (JCN Newswire) - Osaka Gas Co., Ltd. ("Osaka Gas") and Mitsubishi Heavy Industries, Ltd. ("MHI") today commenced operation of CO2NNEX?(1),
Ryder System (NYSE:R) reported better-than-expected third-quarter financial results on Thursday.
Ryder System NYSE: R reported third-quarter results that included a 21% increase in comparable earnings per share, citing strategic initiatives, contractual revenue growth and improving conditions in used vehicle sales and commercial rental.
Ryder System, Inc. (R) Q3 2026 Earnings Call Transcript
MIDLAND, VA / ACCESS Newswire / October 22, 2026 / Smith-Midland Corporation (NASDAQ:SMID), a leading manufacturer of innovative precast concrete products for transportation, infrastructure, and building construction, has secured a $2.2 million contract to manufacture and supply its proprietary SlenderWall® architectural precast wall system for the new Drew Middle School in Stafford County, Virginia. Manufacturing is scheduled to begin at Smith-Midland's Virginia facility in February 2027, with installation scheduled to start in May 2027.
The headline numbers for Ryder (R) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 22, 2026 | 4.15 | 4.33 | Beat 4.3% | $2.76B |
| Jul 23, 2026 | 3.69 | 3.73 | Beat 1.1% | $3.35B |
| Apr 23, 2026 | 2.27 | 2.54 | Beat 11.9% | $3.13B |
| Feb 11, 2026 | 3.66 | 3.59 | Miss -1.9% | $3.17B |
| Oct 23, 2025 | 3.56 | 3.57 | Beat 0.3% | $3.17B |
| Jul 24, 2025 | 3.11 | 3.32 | Beat 6.8% | $3.19B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 10-Q | Oct 22, 2026 | 2026-10-22 16:56:25 | View |
| 8-K | Oct 22, 2026 | 2026-10-22 06:55:41 | View |
| 4 | Oct 5, 2026 | 2026-10-05 16:16:18 | View |
| 4 | Sep 1, 2026 | 2026-09-01 16:16:14 | View |
| 4 | Aug 19, 2026 | 2026-08-19 16:59:31 | View |
| SC 13G | Jul 31, 2026 | 2026-07-31 10:47:35 | View |
| 424B3 | Jul 27, 2026 | 2026-07-27 16:57:16 | View |
| 424B3 | Jul 27, 2026 | 2026-07-27 08:44:01 | View |
| 10-Q | Jul 23, 2026 | 2026-07-23 16:48:56 | View |
| 8-K | Jul 23, 2026 | 2026-07-23 06:55:24 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | R | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 20.6x | 11.0x · sector 18.4x | In line |
| Forward P/E (FY26E) | 18.1x | EPS est. 15.00 | In line |
| Price / Book | 3.5x | 1.9x | Elevated |
| Price / Sales | 0.8x | 0.5x | Elevated |
| EV / EBITDA | 4.8x | 4.3x | In line |
| Return on equity | 17.7% | — | Healthy |
| Gross margin | 18.7% | 20.9% | In line |
| Debt / Equity | 2.42 | 2.65 | Levered |
| Piotroski / Altman Z | 7/9 | Z 1.60 | Distress |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure